Lataa...
Safety and efficacy of elbasvir/grazoprevir for the treatment of chronic hepatitis C: current evidence
Treatments for hepatitis C virus (HCV) have advanced greatly, becoming more efficacious with fewer adverse events, due to the availability of direct-acting antiviral agents, which target specific steps in the HCV life cycle. Recently, a combination regimen consisting of the HCV nonstructural protein...
Tallennettuna:
| Julkaisussa: | Drug Des Devel Ther |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6132225/ https://ncbi.nlm.nih.gov/pubmed/30233138 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S133697 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|